Antithrombin III Deficiency
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Patients/methods We studied 30 patients with antithrombin deficiency but no defects in the gene encoding this key anticoagulant (SERPINC1).
|
27214821 |
2016 |
Antithrombin III Deficiency
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Most cases with antithrombin deficiency carried genetic defects affecting exons or flanking regions of SERPINC1.We aimed to identify regulatory mutations inSERPINC1 through sequencing the promoter, intron 1 and 2 of this gene in 23 patients with antithrombin deficiency but without known genetic defects.
|
27003919 |
2016 |
Antithrombin III Deficiency
|
1.000 |
CausalMutation
|
disease |
CLINVAR |
Molecular characterization of antithrombin III (ATIII) variants using polymerase chain reaction. Identification of the ATIII Charleville as an Ala 384 Pro mutation.
|
2794060 |
1989 |
Antithrombin III Deficiency
|
1.000 |
GeneticVariation
|
disease |
UNIPROT |
Molecular basis of inherited antithrombin deficiency in Portuguese families: identification of genetic alterations and screening for additional thrombotic risk factors.
|
15164384 |
2004 |
Antithrombin III Deficiency
|
1.000 |
GeneticVariation
|
disease |
UNIPROT |
Molecular basis of antithrombin type I deficiency: the first large in-frame deletion and two novel mutations in exon 6.
|
7878627 |
1994 |
Antithrombin III Deficiency
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Molecular basis of SERPINC1 mutations in Japanese patients with antithrombin deficiency.
|
31030036 |
2019 |
Antithrombin III Deficiency
|
1.000 |
CausalMutation
|
disease |
CLINVAR |
Molecular basis for hereditary antithrombin III quantitative deficiencies: a stop codon in exon IIIa and a frameshift in exon VI.
|
1873224 |
1991 |
Antithrombin III Deficiency
|
1.000 |
GeneticVariation
|
disease |
UNIPROT |
Molecular bases of antithrombin deficiency in French families: identification of seven novel mutations in the antithrombin gene.
|
10997988 |
2000 |
Antithrombin III Deficiency
|
1.000 |
Biomarker
|
disease |
MGD |
Life-threatening thrombosis in mice with targeted Arg48-to-Cys mutation of the heparin-binding domain of antithrombin.
|
14592998 |
2003 |
Antithrombin III Deficiency
|
1.000 |
GeneticVariation
|
disease |
UNIPROT |
Intracerebral hemorrhage associated with a novel antithrombin gene mutation in a neonate.
|
11713457 |
2001 |
Antithrombin III Deficiency
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Inherited quantitative (type I) or qualitative (type II) antithrombin deficiency (ATD) due to mutations in the SERPINC1 gene is a well-known risk factor for venous thromboembolism.
|
28300866 |
2017 |
Antithrombin III Deficiency
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
In one of these families antithrombin III deficiency is caused by hemizygosity of the ATIII locus.
|
3663935 |
1987 |
Antithrombin III Deficiency
|
1.000 |
GeneticVariation
|
disease |
UNIPROT |
Important role of arginine 129 in heparin-binding site of antithrombin III. Identification of a novel mutation arginine 129 to glutamine.
|
2229057 |
1990 |
Antithrombin III Deficiency
|
1.000 |
GeneticVariation
|
disease |
UNIPROT |
Impaired cotranslational processing as a mechanism for type I antithrombin deficiency.
|
9845533 |
1998 |
Antithrombin III Deficiency
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Impact of the type of SERPINC1 mutation and subtype of antithrombin deficiency on the thrombotic phenotype in hereditary antithrombin deficiency.
|
24196373 |
2014 |
Antithrombin III Deficiency
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Identification of mutations in the SERPINC1 gene has revealed different mechanisms responsible for antithrombin deficiency.
|
20435622 |
2010 |
Antithrombin III Deficiency
|
1.000 |
GeneticVariation
|
disease |
UNIPROT |
Hereditary antithrombin deficiency: heterogeneity of the molecular basis and mortality in Dutch families.
|
7994035 |
1994 |
Antithrombin III Deficiency
|
1.000 |
CausalMutation
|
disease |
CLINVAR |
Heparanase Activates Antithrombin through the Binding to Its Heparin Binding Site.
|
27322195 |
2016 |
Antithrombin III Deficiency
|
1.000 |
CausalMutation
|
disease |
CLINVAR |
Founder effect is responsible for the p.Leu131Phe heparin-binding-site antithrombin mutation common in Hungary: phenotype analysis in a large cohort.
|
26748602 |
2016 |
Antithrombin III Deficiency
|
1.000 |
GeneticVariation
|
disease |
CLINVAR |
Founder effect is responsible for the p.Leu131Phe heparin-binding-site antithrombin mutation common in Hungary: phenotype analysis in a large cohort.
|
26748602 |
2016 |
Antithrombin III Deficiency
|
1.000 |
GeneticVariation
|
disease |
UNIPROT |
Five novel and four recurrent point mutations in the antithrombin gene causing venous thrombosis.
|
12894857 |
2003 |
Antithrombin III Deficiency
|
1.000 |
GeneticVariation
|
disease |
CLINVAR |
Distinct frequencies and mutation spectrums of genetic thrombophilia in Korea in comparison with other Asian countries both in patients with thromboembolism and in the general population.
|
24162787 |
2014 |
Antithrombin III Deficiency
|
1.000 |
CausalMutation
|
disease |
CLINVAR |
Discordant diagnoses obtained by different approaches in antithrombin mutation analysis.
|
24956267 |
2014 |
Antithrombin III Deficiency
|
1.000 |
GeneticVariation
|
disease |
CLINVAR |
Diagnostic high-throughput sequencing of 2396 patients with bleeding, thrombotic, and platelet disorders.
|
31064749 |
2019 |
Antithrombin III Deficiency
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Detection and characterisation of large SERPINC1 deletions in type I inherited antithrombin deficiency.
|
19760264 |
2010 |